This page has been archived. It still supports good pharmacy practice; however, you may find some outdated terminology or broken links.
RPS Quick Reference Guide
From the 1st November 2018, the law changes widening access to cannabis-based products for medicinal use in humans in England, Scotland and Wales. (See The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018).
Cannabis-based product for medicinal use in humans’ can be available for medicinal use if:
Become a Royal Pharmaceutical Society member to view this content.
JOIN TODAY LOG IN